A top health professor has been appointed as the new chair of a national organisation of consultant physicians in Britain who specialise in diabetes.
Professor Ketan Dhatariya will take charge of the Association of British Clinical Diabetologists (ABCD) from June 2023 when the current chair Dr Dipesh Patel completes his term of office.
A distinguished Leicester GP and researcher who has earned himself a global reputation has received a top accolade for his remarkable career achievements.
Professor Kamlesh Khunti CBE, Director of the National Institute for Health Research (NIHR) Applied Research Collaboration (ARC) East Midlands and Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, has picked up a Lifetime Achievement Award from the Primary Care Diabetes Society (PCDS).
A largescale new study offers a new approach to treating type 2 diabetes by putting people living with the condition in charge of their own medication.
The TriMaster study is the first to allow people with type 2 diabetes to choose their own medication, after trying three different drugs in succession. It concluded the approach could be a new way of finding the best treatment.
Individuals on SGLT2 inhibitors are 37 per cent less likely to develop kidney disease or acute kidney injury compared to those not taking the medication, new evidence shows.
A team of researchers have found that these drugs can protect everyone from progressing renal problems, irrespective of their diabetes status, kidney function or whether they have primary kidney disease.
Adolescents living with obesity can reduce their body weight by taking a once-weekly treatment of a 2.4-mg dose of semaglutide alongside following a healthy lifestyle, according to a study published in the New England Journal of Medicine.
A team of researchers analysed the health outcomes of 201 overweight teenagers, all of whom had at least one coexisting weight-related condition.
The evolution of diabetes-related technologies was discussed by a former optometrist in the latest online interview for the Diabetes Times.
Jenny Hirst, Co-Founder of the charity InDependent Diabetes Trust (IDDT), spoke with DT editor Oliver Jelley about how diabetes technologies have advanced over the years and the barriers associated with these developments.
High blood glucose levels are associated with an increased number of root caries in adults with or without type 2 diabetes, latest research demonstrates.
During the study, a total of 39 adults underwent a dental examination, as well as salivary glucose, fasting blood glucose and glycated haemoglobin measurements.
A new study has found an association between good type 1 diabetes management and the use of GLP-1RA receptor agonists and SGLT2 inhibitors in real-world practice. To read more, click here.
The use of SGLT2 inhibitors was associated with a reduced risk of heart failure in people living with cancer and diabetes, according to research published in the British Medical Journal. To read more, click here.
GLP-1 receptor agonists and SGLT-2 inhibitors are more beneficial than sulfonylureas for people with chronic obstructive pulmonary disease and type 2 diabetes, according to research published in the British Medical Journal.
During the study, the academics assessed the health outcomes of thousands of people using GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors and sulfonylureas.
Hundreds of thousands of people living with type 2 diabetes in Wales are missing out on vital free education. To read more, click here.
Three health organisations have appointed 17 international scientists to advise on its huge investment into type 1 diabetes. To read more, click here.
The pharmaceutical market aimed at tackling type 2 diabetes (T2D) is vibrant, to say the least. To read more, click here.
Individuals with type 2 diabetes can achieve remission without receiving annual care processes. To read more, click here.
Diabetes footcare clinicians who have developed unique processes, innovations, audits or research are invited to share their findings at the English Diabetes Footcare Network’s third virtual national conference taking place next Spring.
Latest research and examples of best practice will be delivered by expert speakers at the EDFN’s online national conference, taking place on Friday, April 21, 2023.
Gestational diabetes is associated with more diverse cardiovascular outcomes than previously considered, latest research has suggested. To read more, click here.
Capsulin oral insulin administered twice a day at a dose of 150iu per capsule is a safe treatment option for people with type 2 diabetes. To read more, click here.
It's been that time of the year again. A diabetes conference, and one of the flagships of the year. The European Association of Study for Diabetes conference in Stockholm. And with time, the way one sees conferences or gains something or anything from them has changed for me personally. To read more, click here.
Bringing you the latest jobs from around the country within the field of diabetes.
Diabetes Specialist Nurse – Royal Devon University Healthcare NHS Foundation Trust
Consultant Nurse Diabetes – Royal Free London NHS Foundation Trust
Consultant in Diabetes & Endocrinology – West Suffolk NHS Foundation Trust
Specialist Diabetes Dietitian – University Hospitals of Derby and Burton NHS Foundation Trust
With thanks to our sponsors
Join the expanding diabetes community on Twitter and follow us for the latest diabetes news updates at @DiabetesTimes.
We are now on YouTube where you will find interviews with leading figures within the field of diabetes. Click here to visit our page.
